BioMarin to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on Wednesday, February 23 at 4:30pm ET

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a conference call and webcast on February 23, 2022, at 4:30 p.m. ET to discuss its fourth quarter and full year 2021 financial results.

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a conference call and webcast on February 23, 2022, at 4:30 p.m. ET to discuss its fourth quarter and full year 2021 financial results. The event will feature insights from CEO Jean-Jacques Bienaimé, covering key financial metrics and a general business update. Investors can access the live audio via the company’s investor section at www.biomarin.com. A replay will be available for one week following the call.

Argus Session date unavailable

-0.98% session move Open Argus

Details

News Market Reaction – BMRN

The recorded move for BMRN in the trading session of this news was -0.98%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Feb. 10, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, February 23rd, at 4:30 p.m. ET to discuss fourth quarter and full year 2021 financial results and provide a general business update.

BioMarin to Host Fourth Quarter and Full Year 2021 Financial Results Call and Webcast on Wed., February 23 at 4:30pm ET

Dial-in Number 
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 6284849

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 6284849

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of seven commercialized products and multiple clinical and preclinical product candidates. For additional information, please visit www.biomarin.com. Information on such a website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2021-financial-results-conference-call-and-webcast-on-wednesday-february-23-at-430pm-et-301479563.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BioMarin announce its fourth quarter and full year 2021 financial results?

BioMarin will announce its financial results on February 23, 2022.

What time is the BioMarin conference call for the financial results?

The conference call will be held at 4:30 p.m. ET.

How can I access the BioMarin financial results call?

Investors can access the call via the investor section of BioMarin's website.

Will there be a replay of the BioMarin financial results call?

Yes, a replay will be available for one week after the call.